Overall Technical outlook

Price Summary

On 2026-04-30, PPLPHARMA's stock opened at 161.47, reached a peak of 162.9, dropped to 156.14, and ended 0.25% up at 161.87, with a volume of 3437613 shares.
Throughout the 52-week period, the stock hit a high of 219.04 and a low of 133.27.
The price outlook for PPLPHARMA is between 150.0 and 265.0, with an average expectation of 200.1, as estimated by 10 analysts.

Technicals

Support and Resistance: The current price sits at 161.87, supported at 158.75 and capped by resistance at 166.52. These levels define a range for PPLPHARMA where the price might stabilize, with 158.75 as a floor and 166.52 as a ceiling.
PPLPHARMA supportResistance 5d1df8
Support/Resistance for PPLPHARMA


Aroon: The current state of the AROON is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
PPLPHARMA aroon 5d1df8
Aroon chart for Piramal Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
PPLPHARMA bbands 5d1df8
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR remains bearish for Piramal Pharma Limited, establishing a crucial resistance level that could hinder any bullish attempts. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult for prices to rise.
PPLPHARMA psar 5d1df8
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The STOCHASTIC is showing a neutral stance, not indicating a clear upward or downward trend for Piramal Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
PPLPHARMA stoch 5d1df8
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
PPLPHARMA trippleSMA 5d1df8
Tripple SMA chart for Piramal Pharma Limited


Before focusing on a company's technical data, such as stock price movements, it's essential to analyze its fundamentals. These include factors like profitability, cash flow, and debt management. Additionally, considering the broader industry landscape—including market trends, competition, and regulatory changes—offers deeper insights. This comprehensive approach allows for a more meaningful interpretation of the company's technical indicators, providing a clearer picture of its financial health and future prospects.